Panion & BF Biotech Inc (1760) — Capital Reinvestment Ratio
Panion & BF Biotech Inc (1760) has a Capital Reinvestment Ratio of 0.40x as of September 2025, meaning it reinvests 0% of its operating cash flow (NT$73.31 Million) in capital expenditures (NT$29.38 Million). Check how tangible is Panion & BF Biotech Inc's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Panion & BF Biotech Inc Capital Reinvestment Ratio (2009–2024)
This chart tracks Panion & BF Biotech Inc's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see 1760 operating cash flow.
Annual Capital Reinvestment Ratio for Panion & BF Biotech Inc (2009–2024)
Year-by-year Capital Reinvestment Ratio for Panion & BF Biotech Inc from 2009 to 2024. See 1760 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.53x | NT$351.19 Million | NT$185.69 Million | ▼ -48.2% |
| 2023 | 1.02x | NT$177.42 Million | NT$181.23 Million | ▲ +151.9% |
| 2022 | 0.41x | NT$489.87 Million | NT$198.64 Million | ▼ -4.3% |
| 2021 | 0.42x | NT$401.23 Million | NT$170.01 Million | ▼ -53.1% |
| 2019 | 0.90x | NT$90.98 Million | NT$82.18 Million | ▲ +80.9% |
| 2018 | 0.50x | NT$78.58 Million | NT$39.23 Million | ▲ +124.9% |
| 2017 | 0.22x | NT$113.97 Million | NT$25.29 Million | ▼ -49.5% |
| 2016 | 0.44x | NT$177.22 Million | NT$77.88 Million | ▼ -60.3% |
| 2015 | 1.11x | NT$58.30 Million | NT$64.60 Million | ▲ +15.3% |
| 2014 | 0.96x | NT$76.11 Million | NT$73.12 Million | ▲ +322.9% |
| 2013 | 0.23x | NT$86.22 Million | NT$19.59 Million | ▼ -96.6% |
| 2012 | 6.73x | NT$3.96 Million | NT$26.63 Million | ▲ +3229.7% |
| 2009 | 0.20x | NT$76.98 Million | NT$15.55 Million | — |